News & Events - Press Release In 2024

Read News By Date

Journal Article Cites AlbuSorb™ PLUS in Functional Mass Spectrometry of COVID-19 Severity

MONMOUTH JUNCTION, NJ, January 30, 2025 -- Biotech Support Group reports on a journal article using AlbuSorb™ PLUS in a functional proteomic study of how anti-protease and complement activity increase with COVID-19 severity.
Read More

Journal Article Cites AlbuSorb™ PLUS in Plasma Proteomic Study Postpartum Dairy Cows

MONMOUTH JUNCTION, NJ, January 6, 2025 -- Biotech Support Group reports on a journal article using AlbuSorb™ PLUS in a proteomic study of how systemic inflammation negatively impacts health and production in dairy cows.
Read More

Cleanascite™ Cited In Study of Alzheimer’s Disease Model of the Integrated Stress Response

MONMOUTH JUNCTION, NJ, December 30, 2024 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation from integrated stress models of disease in mice.
Read More

Cleanascite™ Cited In Study of Biomarkers in Psoriasis and Cardiovascular Disease.

MONMOUTH JUNCTION, NJ, December 16, 2024 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation in a study of HDL-associated Vitamin D Binding Protein (DBP) correlates with disease severity in psoriasis and cardiovascular disease.
Read More

Cleanascite™ Cited in Study of Metabolic Dysfunction–associated Steatotic Liver Disease

MONMOUTH JUNCTION, NJ, December 9, 2024 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation from plasma for mass spectrometry measurement of intact insulin and C-peptide.
Read More

Journal Article Cites AlbuVoid™ in Secretome Study of Human Induced Pluripotent Stem Cells (hiPSCs) Under Investigation For In Vitro Fertilization (IVF)

MONMOUTH JUNCTION, NJ, November 5, 2024 -- Biotech Support Group reports on a recent journal article using AlbuVoid™ for investigating the protein secretome from differentiated ovarian support cells (OSCs).
Read More

HemogloBind™ Cited to Remove Interference in Biomarker Assay for Alpha-Synuclein Tetramers in the Blood of Parkinson’s Patients

MONMOUTH JUNCTION, NJ, November 4, 2024 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of HemogloBind™, to remove Hemoglobin interference prior to an in vitro-cross-linking protocol, to determine the relative levels of disordered and higher-ordered multimeric forms of cytosolic α-synuclein in blood.
Read More

Cleanascite™ Cited To Help Determine the Role of Lipids in Supporting Immunosuppressive Neutrophil Differentiation within Tumors

MONMOUTH JUNCTION, NJ, November 4, 2024 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation from cultured primary human neutrophils isolated from the blood of healthy donors with cancer supernatants from various human cancer cell lines.
Read More

HemogloBind™ Cited to Remove Interference from Hydrogel Particle Capture of Animal Disease Viruses

MONMOUTH JUNCTION, NJ, October 1, 2024 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of HemogloBind™, to remove Hemoglobin interference prior to virus capture using hydrogel particles coupled with chemical affinity baits.
Read More

Journal Article Cites Cleanascite™ To Determine the Role of Fatty Acids in Tumor-Associated Macrophage Polarization in Ovarian Cancer

MONMOUTH JUNCTION, NJ, September 9, 2024 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation from omental conditioned medium (OCM), to in a study of protumoral M2-like macrophages in ovarian cancer.
Read More

Cleanascite™ Sample Prep Improves Nanopore Detection of microRNA from Saliva

MONMOUTH JUNCTION, NJ, August 26, 2024 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of using Cleanascite™ to eliminate interferences from lipids and lipoproteins that nonspecifically interact with a nanopore channel.
Read More

Research Article cite Cleanascite™ in Preparation of Lipid-free Cell Culture Media

MONMOUTH JUNCTION, NJ, August 26, 2024 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of using Cleanascite™ to prepare and contrast lipid-free cell culture media for evaluating Bacterial vaginosis (BV).
Read More

Research Article Cites and NRicher™ and Cleanascite™ in Map of Protein-Protein Interactions

MONMOUTH JUNCTION, NJ, June 27, 2024 -- Biotech Support Group reports on a research article, describing the simplicity and efficiency of their differential proteomic enrichment technology to observe and annotate multiprotein complexes in Toxoplasma gondii, a major food borne pathogen.
Read More

Research Article Cites Cleanascite™ To Help Define the role of Lipids in Macrophage Polarization in Liver Cancer

MONMOUTH JUNCTION, NJ, June 19, 2024 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation technology to determine the role of lipids in a study about the impact of chronic phthalate exposure on liver cancer development.
Read More

Two Biotech Support Group Publications are Cited in a Journal Article Validating the Prognostic Effect of the Tumor-Stroma Ratio

MONMOUTH JUNCTION, NJ, May 7, 2024 -- Biotech Support Group (BSG) reports that two of their joint authorship journal articles were cited in the supporting discussion from the research article:
Read More

BSG Highlights from US HUPO 2024 and MSACL 2024

MONMOUTH JUNCTION, NJ, April 5, 2024 -- Biotech Support Group exhibited at two recent conferences: the US Human Proteome Organization (US HUPO) 2024 Conference, March 9-13, 2024 in Portland, OR, and MSACL 2024 14th Annual Conference organized by the Association for Mass Spectrometry & Advances in the Clinical Lab (MSACL) March 17 - 22, 2024 in Monterey, CA. These conferences highlight the most recent advancements in Proteomics and Mass Spectrometry technology and applications, each with attendance of 400-500 scientists.
Read More

HemogloBind™ is Cited to Remove Hemolysis Interference in A Point-Of-Care Electrochemical Biosensor for Biomarkers of LPS-induced Sepsis

MONMOUTH JUNCTION, NJ, March 28, 2024 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of HemogloBind™, to remove Hemoglobin interference prior to a point-of-care (POC) electrochemical biosensor for sepsis biomarkers.
Read More

Research Article Cite Cleanascite™ To Elucidate the Role of Lipid-Secreted Factors in Alzheimer’s Disease

MONMOUTH JUNCTION, NJ, March 28, 2024 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation technology to determine the role of lipid-associated factors in the brain’s primary resident immune cells – the microglia, and the secretion of toxic long-chain lipids that impair neuron and oligodendrocyte homeostasis.
Read More

Purification of Hemoglobin from a Variety of Animals using HemogloBind™ & HemoVoid™ in Forensic Analysis

MONMOUTH JUNCTION, NJ, February 19, 2024 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of combining two of BSG’s products in series, HemogloBind™ and HemoVoid™, to purify Hemoglobin for peptide mass fingerprinting (PMF) analysis.
Read More

News & Events - Press Release In 2024

Company

Support